| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.2B | $2.7B | $2.1B | $1.7B | $1.2B | $1.1B | $0.3B | $0.3B |
| Cost of Revenue | — | — | — | — | $0.6B | $0.6B | $0.2B | $0.2B |
| Gross Profit | $1.8B | $1.5B | $1.2B | $1.1B | $1.0B | $0.7B | $0.1B | $0.1B |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $0.7B | $0.6B | $0.4B | $0.4B | $0.4B | $0.4B | $0.2B | $0.2B |
| Net Income | $0.3B | $0.2B | $0.2B | $0.2B | $0.3B | $0.4B | $-0.1B | $0.0B |
| EPS (Basic) | $12.25 | $7.78 | $5.71 | $6.42 | $7.05 | $11.85 | $1.09 | $2.06 |
| EPS (Diluted) | $11.52 | $7.43 | $5.49 | $6.19 | $6.79 | $11.70 | $-1.48 | $0.25 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $6.5B | $5.3B | $4.6B | $3.8B | $2.8B | $2.1B | $1.6B | $1.3B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $0.1B | $0.1B | $0.1B | $0.1B | $0.2B | $0.3B | $0.0B | $0.1B |
| Total Liabilities | $5.1B | $4.1B | $3.3B | $2.6B | $1.7B | $1.2B | $1.2B | $1.0B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $1.3B | $1.2B | $1.2B | $1.2B | $1.1B | $0.9B | $0.4B | $0.3B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.8B | $1.5B | $1.2B | $0.9B | $0.5B | $0.7B | $0.8B | $0.7B |
| Investing Cash Flow | $-2.4B | $-1.9B | $-1.5B | $-1.7B | $-1.0B | $0.1B | $-0.9B | $-0.7B |
| Capital Expenditures | — | — | — | — | $0.0B | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $0.7B | $0.3B | $0.5B | $0.7B | $0.4B | $-0.5B | $0.1B | $0.0B |